Trials / No Longer Available
No Longer AvailableNCT03723057
Expanded Access for AG-221
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to AG-221.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG-221 | Oral AG-221 administered as directed by treating physician. |
Timeline
- First posted
- 2018-10-29
- Last updated
- 2019-10-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03723057. Inclusion in this directory is not an endorsement.